The 20th edition of BioAsia – The Marquee Healthcare and Life Sciences event, organized by the Government of Telangana, has announced that the coveted Genome Valley Excellence Award for the year 2023 will be conferred upon Prof. Robert S. Langer, in light of his pioneering research that has led to the development of the first commercial mRNA vaccines used for a variety of infectious diseases. Langer is currently the David H. Koch Institute Professor at Massachusetts Institute of Technology (MIT), USA. He is also being acknowledged for his exemplary research in human health, including the detection, monitoring, and treatment of cancer. A veteran in his field, his remarkable contributions to biomedical and therapeutic research include developing long-term and controlled-release drug delivery systems used for a variety of applications including cancer therapy, insulin, and vaccines.
Related Posts
Michelin India expands its touchpoints in Bengaluru with Michelin Tyres & Services Store in partnership with Cherry Tyre Park
Bengaluru, 29th May 2025: Michelin, the world’s leading tyre technology company, inaugurated its Michelin Tyres & Services Store in Bengaluru, strengthening its…
GAIL (India) Limited Celebrates World Environment Day with People Engagement Activities Across its establishments at Delhi-NCR
New Delhi, 6 June, 2025 – GAIL (India) Limited, India’s leading natural gas company, marked World Environment Day with a series of vibrant…
Shri Jayant Chaudhary Inaugurates NSDC International Academy for Youth Upskilling
Chandigarh, 7th February 2025: Shri Jayant Chaudhary, Hon’ble Minister of State (I/C), Ministry of Skill Development and Entrepreneurship (MSDE) and…
